Macroview Investment Management’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-73
Closed -$2.78K 713
2024
Q1
$2.78K Sell
73
-94
-56% -$3.49K ﹤0.01% 491
2023
Q4
$6.07K Hold
167
0.01% 370
2023
Q3
$5.03K Hold
167
0.01% 426
2023
Q2
$6K Hold
167
0.01% 321
2023
Q1
$5.54K Sell
167
-82
-33% -$2.85K 0.01% 311
2022
Q4
$8.37K Hold
249
0.01% 277
2022
Q3
$9K Sell
249
-1,152
-82% -$41.9K 0.02% 252
2022
Q2
$45K Sell
1,401
-466
-25% -$15.6K 0.07% 95
2022
Q1
$74K Buy
+1,867
New +$73.8K 0.11% 82

Other funds holding BTEC

Macroview Investment Management's BTEC Position: Q2 2024 in Review

Macroview Investment Management sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q2 2024, closing a stake of 73 shares — an estimated $2.78K sold.

Macroview Investment Management first reported a position in BTEC in Q1 2022 and held it in 9 quarters. The position peaked at $74K in Q1 2022. 20 funds tracked by Wall St. Rank hold BTEC as of Q2 2024.

  • Macroview Investment Management reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q2 2024 after selling out during the quarter.
  • Macroview Investment Management sold 73 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q2 2024, an estimated $2.78K.
  • Macroview Investment Management first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q1 2022 and held it in 9 quarters.
  • Macroview Investment Management's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $74K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q2 2024.

Based on Macroview Investment Management's 13F filing for Q2 2024, filed 23 Jul 2024.